Listen on the go
CORRECT!
Next question
touchNEUROLOGY touchNEUROLOGY

Society & Congress Partners

View All
CONy logo 300-300.png

Trending Activities
Play Video
  • Headache Disorders
    touchCLINICAL PERSPECTIVES
    Migraine prevention in the real world: Exploring the role of anti-CGRP antibodies
    Prof. Simona Sacco, Ms Elena Ruiz de la Torre, Prof. Mamoru Shibata, Prof. Christian Lampl, Dr Simy Parikh Translations available:

    Shining a light on the burden of migraine and exploring real-world evidence on anti-CGRP antibodies.

    6 Chapters
Headache Disorders
touchIN CONVERSATION
A patient’s perspective: Best practice for shared decision making in the prevention and treatment of migraine
Dr Patricia Pozo-Rosich, Ms Audrey Craven Translations available:
Watch Time: 54 mins

A migraine specialist and a patient advocate discuss migraine and how decision making between patient and clinician can improve outcomes

Learning objectives
Learning Objectives
  • Appraise the impact of migraine-related disability on patients
  • Evaluate the importance of quality of life improvements for patients with episodic migraine
  • Apply a shared decision making approach in the acute treatment and prevention of episodic migraine

All Activities

View all Education activities

Headache Disorders
Watch Time: 12 mins
touchCLINICAL PERSPECTIVES
Migraine prevention in the real world: Exploring the role of anti-CGRP antibodies
Prof. Simona Sacco, Ms Elena Ruiz de la Torre, Prof. Mamoru Shibata, Prof. Christian Lampl, Dr Simy Parikh Translations available:

Shining a light on the burden of migraine and exploring real-world evidence on anti-CGRP antibodies.

Learning objectives
Learning Objectives
  • Explain the impact of migraine on patient quality of life and the importance of prevention
  • Evaluate real-world data for the use of anti-CGRP antibodies for migraine prevention
  • Formulate a strategy for stopping and restarting anti-CGRP antibodies for migraine prevention
Headache Disorders
Watch Time: 54 mins
touchIN CONVERSATION
A patient’s perspective: Best practice for shared decision making in the prevention and treatment of migraine
Dr Patricia Pozo-Rosich, Ms Audrey Craven Translations available:

A migraine specialist and a patient advocate discuss migraine and how decision making between patient and clinician can improve outcomes

Learning objectives
Learning Objectives
  • Appraise the impact of migraine-related disability on patients
  • Evaluate the importance of quality of life improvements for patients with episodic migraine
  • Apply a shared decision making approach in the acute treatment and prevention of episodic migraine
Alzheimer's Disease & Dementia
Watch Time: 20 mins
touchEXPERT OPINIONS
Recognizing and treating Alzheimer’s disease: The importance of a multidisciplinary approach for early diagnosis and continuum of care
Prof. Jeffrey Cummings, Dr Jennifer Bute Translations available:

Watch two experts in Alzheimer’s disease describe the impact of early diagnosis on therapy and care, from the physician’s and patient’s points of view.

Learning objectives
Learning Objectives
  • Discuss current treatment recommendations and identify challenges in the management of Alzheimer’s disease
  • Describe the importance of a multidisciplinary team approach in the management of Alzheimer’s disease
Epilepsy
Watch Time: 32 mins
touchEXPERT OPINIONS
Can we reach our goals for seizure management in drug-resistant focal epilepsy?
Dr Christian Brandt, Dr Manuel Toledo, Prof. Louise Tyvaert Translations available:

Watch leading experts discuss aspects of the diagnosis and treatment of drug-resistant epilepsy, including up-to-date clinical data.

Learning objectives
Learning Objectives
  • Recognize the impact of recurrent seizures in patients with drug-resistant epilepsy
  • Outline the challenges associated with current standard of care approaches in the management of patients with drug-resistant epilepsy
  • Assess how emerging anti-epileptic drugs might address the unmet treatment needs in patients with drug-resistant focal epilepsy
Parkinson's Disease
Watch Time: 63 mins
touchEXPERT OPINIONS
Looking back over 2018: What have we learnt about optimizing the treatment of advanced Parkinson’s disease?
Prof. Angelo Antonini, Prof. Ray Chaudhuri, Dr Rich Helmich, Prof. Heinz Reichmann

Watch a series of internationally renowned clinical specialists from Europe discuss pivotal data for Parkinson’s disease from key neurology congresses throughout 2018 and consider how these findings may affect clinical practice. The potential implications of these data for optimizing outcomes for patients with advanced Parkinson’s disease are explored from both global and regional perspectives.  

Learning objectives
Learning Objectives
  • Summarize the latest clinical data for emerging treatment options and treatment delivery systems for the management of motor and non-motor symptoms of Parkinson’s disease.
  • Discuss the use of biomarkers for the early identification of Parkinson’s disease, and to facilitate the use of neuroprotective agents.
  • Describe the use of emerging targeted agents and therapeutic strategies to manage treatment side effects and maintain patient quality of life.
IME
Education activities are developed by touchIME for touchNEUROLOGY.

Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.

Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32 social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72